According to the latest report by IMARC Group, titled “Asthma Therapeutics Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2021-2026”, the global asthma therapeutics market reached a value of US$ 17.6 Billion in 2020. Looking forward, IMARC Group expects the global market to continue its moderate growth during the next five years (2021-2026).

Asthma therapeutics include a group of pharmaceutical drugs that are primarily used for treating asthma. The drugs help in mitigating the symptoms of the respiratory disease, which usually gets triggered by exposure to various outdoor and indoor causative agents, including dust, allergens, pollutants, etc. Asthma therapeutics generally include bronchodilators and anti-inflammatory drugs, such as long-acting beta-agonists (LABA), methylxanthine, immunomodulators, corticosteroids, leukotriene modifiers, etc. These drugs aid in expansion of air passage into the lungs, which further enables the proper movement of air to enhance the breathing process. Asthma therapeutics drugs are usually administered via inhalers or nebulizers and are adopted in quick-relief medications and long-term asthma control therapies.

The rising prevalence of asthma due to the growing air pollution levels is currently propelling the adoption of asthma therapeutics. Additionally, the increasing consumer awareness towards the easy availability of effective asthma therapeutics is also catalyzing the market growth. Furthermore, the emergence of combination therapies for treating respiratory diseases, such as asthma, is driving the demand for asthma therapeutics. Numerous pharma companies are constantly focusing on clinical trials of pipeline asthma drugs with higher efficacy and prolonged effect. Several other factors, including the growing healthcare expenditures, continuous upgradation of healthcare infrastructures, extensive R&D activities in the medical sector, etc., are expected to further bolster the global asthma therapeutics market in the coming years.

Get a PDF sample for more detailed market insights

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Asthma Therapeutics 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the asthma therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Biogen Inc.
  • AstraZeneca
  • F. Hoffmann-La Roche AG
  • Boehringer Ingelheim GmbH
  • Merck & Co. Inc.
  • Amgen Inc.
  • GlaxoSmithKline plc.
  • Dainippon Sumitomo Pharma Co. Ltd.

The report has segmented the global asthma therapeutics market on the basis of region, drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

  • Anti-Inflammatory Drugs
  • Bronchodilators
  • Combination Therapies

Breakup by Product Type:

  • Inhalers
    • Dry Powder Inhalers
    • Metered Dose Inhalers
    • Soft Mist Inhalers
  • Nebulizers
    • Pneumatic Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

Breakup by Treatment Type:

  • Quick-Relief Medications
  • Long-Term Asthma Control Medications

Breakup by Route of Administration:

  • Inhalation
  • Oral
  • Parenteral

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore full report with table of contents

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Historical, Current and Future Industry Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Structure of the Global Market
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

Browse Related Reports:

Osteoarthritis Therapeutics Market Report:

Protein Therapeutics Market Report:

Cystic Fibrosis Therapeutics Market Report:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Tags: Asthma Therapeutics Market Size, Asthma Therapeutics Market Growth, global asthma therapeutics market size, Asthma Therapeutics market, Asthma Therapeutics Market Report,  , Global Asthma Therapeutics Market

See Campaign:
Contact Information:
IMARC Group 30 N Gould St, Ste R Sheridan, WY 82801, USA Email: Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Financial Content, Reportedtimes, IPS, iCN Internal Distribution, Extended Distribution, Research Newswire, English


Contact Information:

30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800